COPD diagnosis Researchers have proposed that the COPD Assessment Test (CAT) be used as a US Food and Drug Administration (FDA) clinical outcomes assessment tool. Members of the COPD Biomarker ...

The CAT questionnaire for COPD can distinguish between different types of patients. The COPD Assessment Test (CAT) can be used to distinguish between newly diagnosed patients, those with more ...

The group assignment of chronic obstructive pulmonary disease (COPD) may differ depending on whether the COPD assessment test (CAT) or modified Medical Research Council dyspnoea scale (mMRC) is used.

A high assessment test score for chronic obstructive pulmonary disease (COPD) may predict anxiety in patients, a recent study reported. A high assessment test score for chronic obstructive pulmonary ...

The assessment of chronic obstructive pulmonary disease (COPD) now allows for the evaluation of various patient-reported outcomes (PROs); however, these PROs assess different disease features than ...

After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...